-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Moderna (MRNA)
-
-
-
-
-
-
-
Piper Sandler Starts Generate Biomedicines (GENB) at Overweight
-
-
-
-
-
-
-
Immunitybio Inc (IBRX) PT Raised to $7 at Piper Sandler
-
-
-
-
-
-
-
Piper Sandler Names Arrowhead Pharma (ARWR) 'A Top Pick for 2026', Lifts Stock PT
-
-
-
-
-
-
-
CytomX Therapeutics (CTMX) PT Raised at Piper Sandler Amid 'Encouraging CX-801 Data'
-
-
-
-
-
-
-
NextCure Inc. (NXTC) PT Lowered at Piper Sandler Following the Reverse Stock Split
-
-
-
-
-
-
-
Piper Sandler Assumes Cardiff Oncology (CRDF) at Overweight
-
391 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


